Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-29

Clinical Trial Update: Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and tolerability of tapentadol hydrochloride in adults with severe osteoarthritis pain, including those on WHO Step I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Chronic Pain, Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-29